Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Will oral supplementation with Omega 3 free fatty acids in obese Barrett's esophagus subjects
downregulate pro-neoplastic and pro-inflammatory pathways in the esophagus to
anti-inflammatory pathway?